학술논문
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial: RIVER Trial: Rationale and Design
Document Type
Article
Author
Guimarães, H.P.; de Barros e Silva, P.G.M.; Laranjeira, L.; Kojima, F.; Damiani, L.; Nakagawa, R.H.; dos Santos, J.R.Y.; Sampaio, B.S.; Campos, V.B.; Pavanello, R.; Cavalcanti, A.B.; Berwanger, O.; Liporace, I.L.; Sampaio, R.O.; Tarasoutchi, F.; Paixão, M.; Ferreira, J.F.M.; Hoffmann-Filho, C.R.; Patriota, R.; Leiria, T.L.L.; Lamprea, D.; Precoma, D.B.; Atik, F.A.; Silveira, F.S.; Farias, F.R.; Barreto, D.O.; Almeida, A.P.; Zilli, A.C.; de Souza Neto, J.D.; Cavalcante, M.A.; Figueira, F.A.M.S.; Junior, R.A.; Moisés, V.A.; Fonseca, F.H.; Mesas, C.E.; Ardito, R.V.; Kalil, P.S.A.; Paiva, M.S.M.O.; Maldonado, J.G.A.; de Lima, C.E.B.; D'Oliveira Vieira, R.; Saraiva, J.F.K.; Pinto, I.M.; Magalhães, C.C.; Lopes, R.D.
Source
In: American Heart Journal . (American Heart Journal, January 2021, 231:128-136)
Subject
Language
English
ISSN
10976744
00028703
00028703